T De Pas L Bodei G Pelosi F De Braud G Villa R Capanna G Paganelli Italian Sarcoma Group
10.1038/sj.bjc.6600823
Br J Cancer
2003 Mar 10;88(5):645-7.
CC BY
https://pubmed.ncbi.nlm.nih.gov/12618868/
Fibromatosis, Aggressive / radiotherapy Octreotide / analogs & derivatives Octreotide / therapeutic use Radiopharmaceuticals / therapeutic use Radiotherapy, Adjuvant / methods Receptors, Peptide / therapeutic use
Fibromatosis, Aggressive / radiotherapy Octreotide / analogs & derivatives Octreotide / therapeutic use Radiopharmaceuticals / therapeutic use Radiotherapy, Adjuvant / methods Receptors, Peptide / therapeutic use Case Reports Adult Female Humans Male Recurrence Retrospective Studies Radiopharmaceuticals Receptors, Peptide Octreotide Edotreotide
PMC2376350
12618868
Peptide receptor radiotherapy: a new option for the management of aggressive fibromatosis on behalf of the Italian Sarcoma Group
2003